BioSpace News Archive

BioForest

Adaptive Biotechnologies Announces Medicare Coverage of the clonoSEQ® Assay for MRD Testing in Patients with Multiple Myeloma and Acute Lymphoblastic Leukemia at Multiple Timepoints Throughout Treatment and Remission

Adaptive Biotechnologies announced that Palmetto GBA, a Medicare Administrative Contractor (MAC) and leader in assessing diagnostic technologies through its MolDX program, has established coverage of the clonoSEQ® Assay for Medicare patients with multiple myeloma and B-cell acute lymphoblastic leukemia (ALL).

January 17, 2019
·
5 min read
Drug Development

Acorda Announces The Lancet Neurology Publication of Phase 3 Data for INBRIJA™ (levodopa inhalation powder)

SPAN℠-PD, the efficacy and safety study of INBRIJA (CVT-301), showed significant improvement in motor function during OFF periods in people with Parkinson’s on a carbidopa/levodopa regimen

January 17, 2019
·
12 min read
Business

Ironshore Pharmaceuticals Announces Appointment of Dr. Lewis Warrington as Vice President / Head of Medical Affairs

Ironshore Pharmaceuticals (“Ironshore”), a wholly owned subsidiary of Highland Therapeutics Inc. (“Highland”) and a leader in the commercialization of novel treatments for Attention Deficit Hyperactivity Disorder (ADHD), today announced the appointment of Dr. Lewis Warrington to the position of Vice President / Head of Medical Affairs.

January 17, 2019
·
7 min read
Deals

Bear Real Estate Advisors Represents Global Medical REIT in $17 Million Medical Office Building Acquisition in Greater Los Angeles

Bear Real Estate Advisors announced today that the real estate investment services firm represented Global Medical REIT (NYSE: GMRE) in its acquisition of an approximately 42,000-square-foot, Class A medical office building located in the Los Angeles suburb of Corona, Calif. Global Medical REIT acquired the property for approximately $17 million.

January 17, 2019
·
2 min read